Related Experiment Video
Updated: Sep 16, 2025
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
Chronic Respiratory Disease Prevalence, Burden, and Treatment in Cape Town: A Cross-Sectional Study
Marie Stolbrink1,2, Lisanne Liebenberg2, Tantaswa Ndlelana2
1Department of Lung Health and Tuberculosis, Clinical Sciences Liverpool School of Tropical Medicine Liverpool UK.
Background And Aims:
There is a high burden of respiratory symptoms in South Africa, but accurate classification of diagnoses is challenging. Due to the adverse risk profile, inhaled corticosteroid (ICS) treatment should only be used in specific conditions, such as asthma or chronic obstructive pulmonary disease (COPD) with eosinophilia. Those with tuberculosis or who are HIV-positive may be at particular risk. Hence, establishing underlying diagnoses and indications for ICS treatment is crucial. The primary aim was to establish the underlying diagnosis after investigations, the secondary aim was to identify any indication for ICS treatment (asthma or eosinophilia).
Methods:
We conducted a cross-sectional study of adults attending two hospitals in Cape Town, South Africa, with exacerbations of chronic respiratory diseases. Participants performed investigations at least 8 weeks after recruitment. Questionnaires and extensive investigations (full lung function with bronchodilator reversibility, allergy tests, computed tomography) were completed.
Results:
Between 2021 and 2023, a total of 224 participants were recruited, of whom 101 attended investigations, yet 40 died before they could attend. Most were current (49) or ex-smokers (40). A total of 46 previously had pulmonary tuberculosis. Post-tuberculosis lung disease (PTLD) with COPD (28) or COPD alone (27) were the most common diagnoses. Ten participants had asthma. Serum eosinophilia was present in 19 participants. There was no clear indication for ICS treatment for 5/7 participants who used ICS, and 22/30 who used ICS-long-acting beta-agonists combination.
Conclusion:
COPD and PTLD were more common, asthma and eosinophilia were less prevalent than expected. There was a high symptom burden. Modifiable risks (tuberculosis, smoking) were also common. ICS treatment appeared to be independent of underlying diagnosis and could lead to harm. Approximately 1 in 5 died shortly after admission. Strategies to better serve this patient group are urgently needed.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:22Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation